Overview

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Status:
Completed
Trial end date:
2018-10-04
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of roxadustat for treatment of anemia in patients with chronic kidney disease not on dialysis
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Collaborator:
FibroGen